HOUSTON, TX — A 70-year-old Texas doctor has been federally charged with illegally distributing more than 5.3 million opioid pills through a cash-only Houston clinic using fake patients who never received medical examinations.
James Robles of Weslaco faces up to 60 years in federal prison after prosecutors unsealed an indictment Thursday alleging he operated a massive prescription drug scheme that generated more than $2 million in cash deposits over four years. The Drug Enforcement Administration investigation revealed Robles conspired with “crew leaders” who recruited people to pose as patients, filled his prescriptions at complicit pharmacies, and resold the controlled substances on Houston’s black market. Assistant Attorney General A. Tysen Duva of the Justice Department’s Criminal Division announced the charges alongside DEA Special Agent in Charge Brian C. Leardo.
Court documents filed in the Southern District of Texas show Robles allegedly prescribed approximately 2.9 million hydrocodone pills, 1.3 million oxycodone pills, and 1.1 million carisoprodol pills between 2021 and 2025. Prosecutors say the medical doctor, licensed to practice in Texas, often failed to examine or even see his purported patients before writing prescriptions for the highly addictive substances. “Robles allegedly sold prescriptions to crew leaders who recruited others to pose as patients, filled Robles’ prescriptions at complicit pharmacies and resold the drugs on the black market,” according to the Justice Department’s Thursday announcement. The controlled substances carried substantial street value and were in high demand on Houston’s illegal drug market, federal investigators determined.
The cash-only clinic operation allowed Robles to avoid typical medical billing oversight while generating substantial illegal profits, according to federal prosecutors. Banking records examined by investigators show more than $2 million in cash was deposited into accounts controlled by Robles during less than three years of the alleged conspiracy. The scheme involved multiple participants who helped orchestrate the fake patient visits and subsequent drug distribution network throughout the Houston area. DEA agents identified the clinic as a central hub for prescription drug trafficking that supplied street-level dealers across the region. Federal authorities say the investigation uncovered evidence of systematic fraud designed to circumvent medical licensing requirements and drug scheduling regulations.
The charges come as federal authorities intensify efforts to combat prescription drug fraud nationwide through the Health Care Fraud Strike Force Program. Since March 2007, the program has charged more than 6,200 defendants who collectively billed federal health care programs and private insurers more than $45 billion, according to the Justice Department’s Criminal Division. The Fraud Section leads these efforts across eight strike forces operating in federal districts nationwide. Trial Attorneys Angela Benoit and Andrew Pennebaker of the Criminal Division’s Fraud Section are prosecuting the Robles case. The Centers for Medicare & Medicaid Services is working with the Office of the Inspector General for the Department of Health and Human Services to hold providers accountable for involvement in health care fraud schemes.
Robles faces three federal counts: conspiracy to distribute and dispense controlled substances, distributing and dispensing controlled substances, and maintaining a drug-involved premises. Each count carries a maximum penalty of 20 years in federal prison if convicted. The indictment represents only allegations, and Robles is presumed innocent until proven guilty beyond a reasonable doubt in court. Federal prosecutors have not announced when Robles will make his initial court appearance or whether he has retained legal counsel. The DEA continues investigating the case to identify additional participants in the alleged prescription drug trafficking network. Court records indicate the investigation involved extensive surveillance of the Houston clinic and analysis of prescription patterns that raised red flags with federal drug enforcement officials.
The case highlights ongoing concerns about prescription drug abuse and illegal distribution networks that have contributed to the nation’s opioid crisis. Oxycodone and hydrocodone are powerful pain medications that carry high risk for addiction and are frequently targeted by illegal drug trafficking organizations. Carisoprodol, a muscle relaxant also prescribed by Robles, is similarly controlled due to its potential for abuse and street value. Federal authorities say the Houston clinic case demonstrates how medical professionals can exploit their prescribing authority to fuel illegal drug markets. The investigation revealed systematic violations of medical practice standards designed to ensure controlled substances reach only legitimate patients with valid medical needs requiring such treatments.
Robles’ arrest represents the latest action in federal efforts to prosecute medical professionals who abuse their prescribing privileges for financial gain. The case remains under investigation as federal authorities work to identify the full scope of the alleged prescription drug trafficking network and any additional participants who may face charges.

